Owlet (OWLT) Aktievy
Owlet, Inc. tillhandahåller digitala lösningar för föräldraskap i USA, Storbritannien och internationellt. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 4/6 |
| Framtida tillväxt | 1/6 |
| Tidigare resultat | 0/6 |
| Finansiell hälsa | 6/6 |
| Utdelningar | 0/6 |
Belöningar
Riskanalys
OWLT Community Fair Values
Create NarrativeSee what 19 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Owlet, Inc. Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$4.54 |
| 52 veckors högsta | US$16.94 |
| 52 veckors lägsta | US$4.19 |
| Beta | 1.9 |
| 1 månads förändring | -25.70% |
| 3 månaders förändring | -9.20% |
| 1 års förändring | -39.22% |
| 3 års förändring | 20.11% |
| 5 års förändring | -94.23% |
| Förändring sedan börsintroduktionen | -96.66% |
Senaste nyheter och uppdateringar
Seeking Alpha • Sep 04
Owlet: The Business Is Growing, But The Stock Isn't
Summary Owlet remains a buy despite flat stock performance, supported by strong Q2 results and ongoing business evolution. Q2 revenue hit a record $33.9M (up 29.9% YoY), with gross margin rebounding to 54% and subscription growth driving margin expansion. Management maintained 2026 guidance, forecasting $120M revenue (13.5% growth) and $8M EBITDA, with international and subscription segments as key growth drivers. OWLT's FDA approval and Amazon enforcement could reduce competition, while a direct subscription model and telehealth expansion offer future margin and growth catalysts. Read the full article on Seeking Alpha
Uppdatering av berättelse • Jul 24
OWLT: Customer Adoption And Subscriptions Will Drive Future Upside Potential
Owlet's updated analyst price target shifts from $20 to $15 as analysts factor in revised growth expectations, slightly adjusted discount rates, and a lower future P/E multiple, while still highlighting the potential for upside from increased customer adoption and subscriptions. What’s in the News for Owlet Owlet, Inc.Recent updates
Seeking Alpha • Sep 04
Owlet: The Business Is Growing, But The Stock Isn't
Summary Owlet remains a buy despite flat stock performance, supported by strong Q2 results and ongoing business evolution. Q2 revenue hit a record $33.9M (up 29.9% YoY), with gross margin rebounding to 54% and subscription growth driving margin expansion. Management maintained 2026 guidance, forecasting $120M revenue (13.5% growth) and $8M EBITDA, with international and subscription segments as key growth drivers. OWLT's FDA approval and Amazon enforcement could reduce competition, while a direct subscription model and telehealth expansion offer future margin and growth catalysts. Read the full article on Seeking AlphaUppdatering av berättelse • Jul 24
OWLT: Customer Adoption And Subscriptions Will Drive Future Upside Potential
Owlet's updated analyst price target shifts from $20 to $15 as analysts factor in revised growth expectations, slightly adjusted discount rates, and a lower future P/E multiple, while still highlighting the potential for upside from increased customer adoption and subscriptions. What’s in the News for Owlet Owlet, Inc.
Uppdatering av berättelse • Jul 10
OWLT: Guidance Reset And Subscriptions Are Expected To Drive Upside
Analysts have lowered their price target on Owlet stock from $13 to $10, reflecting a reset in expectations while still highlighting what they see as an underappreciated brand with potential for upside as customer adoption and subscription features develop. What’s in the News for Owlet Owlet, Inc.
Uppdatering av berättelse • Jun 26
OWLT: Guidance Reset And Adoption Initiatives Will Support Future Execution
Analysts have trimmed their fair value estimate for Owlet from $17.00 to $13.00, reflecting updated assumptions on growth, profitability, and P/E, while still pointing to potential upside supported by views that the recent guidance reset and improving hardware and subscription features could attract more customers over time. What's in the News for Owlet Owlet launched Dream Sight and Dream Duo 3 across Australia and New Zealand, bringing its full lineup of baby monitoring products, including Dream Sock, to those markets for the first time.Uppdatering av berättelse • Jun 04
OWLT: Softer Q1 Guide Seen Preceding Stronger 2026 Second Half
Narrative Update The analyst price target for Owlet has been reduced from $20 to $15, with analysts pointing to softer Q1 guidance, while also noting 2026 expectations that suggest a more robust back half of that year. What's in the News Owlet launched Dream Sight and Dream Duo 3 across Australia and New Zealand, expanding its full baby monitoring product lineup in those markets, including Dream Sock, Dream Sight, and Dream Duo 3.Uppdatering av berättelse • May 11
OWLT: Softer Q1 Outlook Seen Setting Up Stronger 2026 Finish
Analysts have trimmed their price target on Owlet stock to $15 from $20, citing Q1 guidance that came in below expectations, while highlighting that 2026 guidance still lines up with prior views and points to a potentially stronger second half of that year. Analyst Commentary Bearish analysts are signaling a more cautious stance on Owlet after recent guidance, using the reduced price target as a way to reset expectations while still acknowledging longer term potential.Uppdatering av berättelse • Apr 20
OWLT: Softer Q1 Outlook Expected To Set Up Stronger Second Half 2026
Analysts have lowered their price target on Owlet to $15 from $20, citing slightly softer Q1 guidance versus expectations. They also note that current management guidance indicates the second half of 2026 could be more robust.Uppdatering av berättelse • Apr 05
OWLT: Guidance And Partnerships Are Expected To Support A Stronger Second Half 2026
Analysts have revised Owlet's price target to $15, down from $19, reflecting mixed near term guidance and updated models that still indicate the possibility of stronger performance in the longer term. Analyst Commentary Recent research updates on Owlet point to a more cautious tone, even as some longer term expectations remain in place.Uppdatering av berättelse • Mar 22
OWLT: Updated Modeling And Healthcare Partnerships Will Support Stronger Second Half 2026
Analysts have updated their view on Owlet, trimming the consolidated price target to $15 as they factor in softer Q1 guidance, a higher assumed P/E multiple and lower projected revenue growth and profit margins, while still highlighting expectations for a stronger second half of 2026. Analyst Commentary Recent research highlights a more measured tone around Owlet, with some price targets recalibrated as analysts balance solid past execution with softer near term guidance and updated valuation assumptions.Uppdatering av berättelse • Mar 08
OWLT: Updated Modeling And New Healthcare Partnerships Will Support Future Upside Potential
Analysts have adjusted their outlook on Owlet, trimming the price target from $14 to $13 as they factor in updated expectations for growth, profitability, and future P/E assumptions that are informed by recent research highlighting mixed near term guidance alongside longer term projections that are described as steady. Analyst Commentary Recent Street research reflects a mixed but increasingly cautious tone around Owlet, with some bearish analysts trimming price targets as they reassess growth visibility and execution risk against current valuation.Uppdatering av berättelse • Feb 22
OWLT: Updated Modeling And FDA Pathways Will Support Future Upside Potential
Analysts have lifted their price target on Owlet to $19 from $15, citing updated modeling assumptions following a transfer of coverage. Analyst Commentary Recent research points to a reset in expectations around Owlet, with updated modeling used to support a US$19 price target.Uppdatering av berättelse • Feb 07
OWLT: Additional Liquidity And Partnerships Will Extend Funding Runway
Analysts have lifted their price target on Owlet to US$20 from US$15, citing updated models that factor in recent Street research highlighting a refreshed coverage framework and additional liquidity that supports the company’s plans. Analyst Commentary Bullish analysts are pointing to recent price target revisions as a sign of growing confidence in Owlet’s ability to execute on its plans, especially as fresh research coverage and additional liquidity are incorporated into updated models.Analysartikel • Feb 05
Some Owlet, Inc. (NYSE:OWLT) Shareholders Look For Exit As Shares Take 31% Pounding
Owlet, Inc. ( NYSE:OWLT ) shares have retraced a considerable 31% in the last month, reversing a fair amount of their...Uppdatering av berättelse • Jan 24
OWLT: Liquidity And New Coverage Models Will Support Future Execution
Narrative Update: Owlet Analyst Price Target Shift Analysts have lifted their price target on Owlet from US$16 to US$17, reflecting updated models that factor in recent target increases on the Street and comfort with assumptions around fair value, discount rate, and a higher future P/E multiple. Analyst Commentary Recent Street research has tilted constructive on Owlet, with bullish analysts lifting price targets and updating their models following new company information and a transfer of coverage.Uppdatering av berättelse • Jan 09
OWLT: Liquidity And Regulatory Progress Will Support Execution While Risks Remain
Analysts have lifted their price target on Owlet to US$16.00 from US$14.88, citing refreshed models that factor in recent price target increases from firms updating coverage and highlighting added liquidity to support R&D into 2026. Analyst Commentary Recent Street research has trended constructive on Owlet, with higher price targets reflecting refreshed coverage models and a focus on liquidity and execution into 2026.Uppdatering av berättelse • Dec 15
OWLT: FDA Focus And Global Expansion Will Shape Balanced Risk Profile
Analysts have raised their fair value estimate for Owlet from $11.00 to $14.00 per share, citing stronger projected revenue growth, improved liquidity from a recent stock offering, and an FDA highlighted competitive moat that supports a higher long term price target. Analyst Commentary Recent research commentary has underscored a more constructive outlook on Owlet, with price targets moving higher following what was described as a solid quarter and improved balance sheet flexibility.Analysartikel • Dec 05
There's Reason For Concern Over Owlet, Inc.'s (NYSE:OWLT) Massive 67% Price Jump
Owlet, Inc. ( NYSE:OWLT ) shares have continued their recent momentum with a 67% gain in the last month alone. The...Uppdatering av berättelse • Dec 01
OWLT: Regulatory Momentum And FDA Approval Will Drive Market Leadership Forward
Analysts have increased their price target for Owlet to $15.50 from $12.00, citing a solid quarter, improved liquidity, and the company's status as the only FDA-approved over-the-counter infant monitoring device as key drivers for their more favorable outlook. Analyst Commentary Recent analyst perspectives on Owlet reflect a mixed but largely positive sentiment following the company's most recent financial results and regulatory developments.Uppdatering av berättelse • Nov 17
OWLT: Regulatory Approvals And Increased Liquidity Will Support Long-Term Market Leadership
Analysts have raised their price target for Owlet from $13.20 to $14.83. They cite stronger revenue growth, improved profitability, and increased liquidity following the company's solid recent quarter.Analysartikel • Oct 07
Further Upside For Owlet, Inc. (NYSE:OWLT) Shares Could Introduce Price Risks After 31% Bounce
Owlet, Inc. ( NYSE:OWLT ) shares have had a really impressive month, gaining 31% after a shaky period beforehand. The...Uppdatering av berättelse • Aug 09
Telehealth Partnerships And AI Insights Will Broaden Digital Health Markets
Driven by strong consumer demand for its FDA-cleared Dream Sock and a unique competitive position, analysts have raised Owlet’s price target from $12.30 to $13.20. Analyst Commentary The $300 Dream Sock is currently a best-selling smart baby monitor on Amazon, demonstrating strong consumer traction.Analysartikel • Jun 14
Investors Still Aren't Entirely Convinced By Owlet, Inc.'s (NYSE:OWLT) Revenues Despite 34% Price Jump
Owlet, Inc. ( NYSE:OWLT ) shares have continued their recent momentum with a 34% gain in the last month alone. The last...
Ny berättelse • Apr 10
Dream Sock, BabySat, And Company360 Will Expand Global Healthcare Access
Owlet's FDA and CE approvals pave the way for global market expansion, boosting international revenue potential.Aktieägarnas avkastning
| OWLT | US Medical Equipment | US Marknad | |
|---|---|---|---|
| 7D | -6.6% | 0.7% | -1.1% |
| 1Y | -39.2% | -15.8% | 11.7% |
Avkastning vs industri: OWLT presterade sämre än US Medical Equipment branschen som gav -15.8 % under det senaste året.
Avkastning vs Marknaden: OWLT presterade sämre än US marknaden som gav 11.7 % under det senaste året.
Prisvolatilitet
| OWLT volatility | |
|---|---|
| OWLT Average Weekly Movement | 8.6% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.9% |
Stabil aktiekurs: OWLT har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: OWLT s veckovolatilitet ( 9% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 2012 | 111 | Kurt Workman | www.owletcare.com |
Owlet, Inc. tillhandahåller digitala lösningar för föräldraskap i USA, Storbritannien och internationellt. Företaget erbjuder en digital plattform för föräldraskap som ger föräldrar data och insikter i realtid. Bolaget tillhandahåller också strumpmonitorer, inklusive Dream Sock, en bärbar hälsomonitor för spädbarn utrustad med pulsoximetriteknik som spårar vitala tecken, såsom puls, aktivitet, syrenivå och sömnmönster; BabySat, som är avsedd för spädbarn med tillstånd, inklusive respiratoriskt syncytialvirus, lunginflammation, bronkit, krupp och andra diagnoser; och Dream Sight, en ljud- och videomonitor som gör det möjligt för föräldrar att övervaka sitt barn.
Owlet, Inc. Sammanfattning av grunderna
| OWLT grundläggande statistik | |
|---|---|
| Börsvärde | US$135.59m |
| Vinst(TTM) | -US$13.00m |
| Intäkter(TTM) | US$114.41m |
1.2x
P/S-förhållande-10.2x
P/E-förhållandeÄr OWLT övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| OWLT resultaträkning (TTM) | |
|---|---|
| Intäkter | US$114.41m |
| Kostnad för intäkter | US$51.97m |
| Bruttovinst | US$62.44m |
| Övriga kostnader | US$75.44m |
| Intäkter | -US$13.00m |
Senast redovisade vinst
Jun 30, 2026
Nästa vinstdatum
n/a
| Vinst per aktie (EPS) | -0.44 |
| Bruttomarginal | 54.57% |
| Nettovinstmarginal | -11.36% |
| Skuld/egenkapitalförhållande | 46.3% |
Hur har OWLT utvecklats på lång sikt?
Se historisk utveckling och jämförelseFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/09/16 09:38 |
| Aktiekurs vid dagens slut | 2026/09/16 00:00 |
| Intäkter | 2026/06/30 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Owlet, Inc. bevakas av 9 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Allen Lutz | BofA Global Research |
| James Suva | Citigroup Inc |
| Ilya Zubkov | Freedom Broker |